April 2, 2012
Cardiologists’ study named a breakthrough of 2011
David Kass, a professor of cardiology in the School of Medicine, and his lab have been recognized in the annual Signaling Breakthroughs of 2011, published by the journal Science Signaling, for their groundbreaking 2011 study published in Science Translational Medicine.
The Johns Hopkins researchers’ study revealed how a pacemaker therapy for heart failure, known as cardiac resynchronization therapy, works at the biological level, opening the door to drugs or genetic therapies that could mimic the effect of the pacemaker.
Their work was recognized as among the most exciting cell signaling research projects to emerge last year.